Literature DB >> 33990619

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors1,2, Andreas M Schmitt3,4, Perrine Janiaud3, Janneke Van't Hooft1,5, Sherief Abd-Elsalam6, Ehab F Abdo7, Benjamin S Abella8, Javed Akram9, Ravi K Amaravadi10, Derek C Angus11,12, Yaseen M Arabi13, Shehnoor Azhar14, Lindsey R Baden15, Arthur W Baker16, Leila Belkhir17, Thomas Benfield18, Marvin A H Berrevoets19, Cheng-Pin Chen20, Tsung-Chia Chen21, Shu-Hsing Cheng20, Chien-Yu Cheng20, Wei-Sheng Chung21, Yehuda Z Cohen22, Lisa N Cowan22, Olav Dalgard23,24, Fernando F de Almeida E Val25, Marcus V G de Lacerda25,26, Gisely C de Melo25,27, Lennie Derde28,29, Vincent Dubee30, Anissa Elfakir31, Anthony C Gordon32, Carmen M Hernandez-Cardenas33, Thomas Hills34,35, Andy I M Hoepelman36, Yi-Wen Huang37, Bruno Igau22, Ronghua Jin38, Felipe Jurado-Camacho33, Khalid S Khan39, Peter G Kremsner40,41,42, Benno Kreuels43,44, Cheng-Yu Kuo45, Thuy Le16, Yi-Chun Lin20, Wu-Pu Lin46, Tse-Hung Lin37, Magnus Nakrem Lyngbakken24,47, Colin McArthur34,35,48, Bryan J McVerry49, Patricia Meza-Meneses50, Wuelton M Monteiro25,27, Susan C Morpeth51, Ahmad Mourad52, Mark J Mulligan53,54, Srinivas Murthy55, Susanna Naggie16, Shanti Narayanasamy16, Alistair Nichol48,56,57,58, Lewis A Novack59, Sean M O'Brien60, Nwora Lance Okeke16, Léna Perez61, Rogelio Perez-Padilla62, Laurent Perrin63, Arantxa Remigio-Luna62, Norma E Rivera-Martinez64, Frank W Rockhold60, Sebastian Rodriguez-Llamazares62, Robert Rolfe16, Rossana Rosa65, Helge Røsjø24,66, Vanderson S Sampaio25,67, Todd B Seto68,69, Muhammad Shahzad70, Shaimaa Soliman71, Jason E Stout16, Ireri Thirion-Romero62, Andrea B Troxel72, Ting-Yu Tseng21, Nicholas A Turner16, Robert J Ulrich73, Stephen R Walsh15, Steve A Webb48,74, Jesper M Weehuizen36, Maria Velinova75, Hon-Lai Wong76, Rebekah Wrenn16, Fernando G Zampieri77,78,79, Wu Zhong80, David Moher81, Steven N Goodman1,82,83, John P A Ioannidis1,82,83,84,85, Lars G Hemkens86,87,88.   

Abstract

Entities:  

Year:  2021        PMID： 33990619     DOI： 10.1038/s41467-021-23559-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
  5 in total

Review 1.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

Review 2.  Efficacy of early treatment with hydroxychloroquine in people with mild to moderate COVID-19: a systematic review and meta-analysis.

Authors:  Adrian V Hernandez; John Ingemi; Michael Sherman; Vinay Pasupuleti; Joshuan J Barboza; Alejandro Piscoya; Yuani M Roman; C Michael White
Journal:  Arch Med Sci       Date:  2021-10-24       Impact factor: 3.707

Review 3.  Strategies for drug repurposing against coronavirus targets.

Authors:  Poppy O Smith; Peiqin Jin; Khondaker Miraz Rahman
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-12-04

Review 4.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

5.  Is Endemicity a Solution for the COVID-19 Pandemic? The Four E's Strategy for the Public Health Leadership.

Authors:  Leonardo Villani; Maria Rosaria Gualano; Walter Ricciardi
Journal:  Front Public Health       Date:  2022-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.